rs377302275
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 0P and 2B. BP4_Moderate
The NM_000212.3(ITGB3):c.1976G>A(p.Arg659His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000843 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_000212.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITGB3 | ENST00000559488.7 | c.1976G>A | p.Arg659His | missense_variant | Exon 12 of 15 | 1 | NM_000212.3 | ENSP00000452786.2 | ||
ENSG00000259753 | ENST00000560629.1 | n.1940G>A | non_coding_transcript_exon_variant | Exon 12 of 18 | 2 | ENSP00000456711.2 | ||||
ITGB3 | ENST00000696963.1 | c.1976G>A | p.Arg659His | missense_variant | Exon 12 of 14 | ENSP00000513002.1 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152130Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000438 AC: 11AN: 251394Hom.: 0 AF XY: 0.0000589 AC XY: 8AN XY: 135874
GnomAD4 exome AF: 0.0000882 AC: 129AN: 1461810Hom.: 0 Cov.: 31 AF XY: 0.0000770 AC XY: 56AN XY: 727210
GnomAD4 genome AF: 0.0000460 AC: 7AN: 152130Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Variant summary: ITGB3 c.1976G>A (p.Arg659His), also reported as Arg633His, results in a non-conservative amino acid change located in the Integrin beta tail domain (IPR012896) of the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 4.4e-05 in 251394 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in ITGB3 causing Glanzmann Thrombasthenia 2, allowing no conclusion about variant significance. c.1976G>A has been reported in the literature in at least 1 individual affected with alloimmune thrombocytopenia (example, Simsek_1994, Simsek_1997). These report(s) do not provide unequivocal conclusions about association of the variant with ITGB3-related conditions. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 7863631, 9163597). No submitters have cited clinical-significance assessments for this variant to ClinVar. Based on the evidence outlined above, the variant was classified as uncertain significance. -
not provided Uncertain:1
This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 659 of the ITGB3 protein (p.Arg659His). This variant is present in population databases (rs377302275, gnomAD 0.01%). This variant has not been reported in the literature in individuals affected with ITGB3-related conditions. Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt ITGB3 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at